ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
OS Therapies Incorporated

OS Therapies Incorporated (OSTX)

2.23
0.24
(12.06%)
Cerrado 15 Febrero 3:00PM
2.08
-0.15
(-6.73%)
Fuera de horario: 6:59PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
2.08
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
38,584,386
2.16 Rango del Día 2.98
1.58 Rango de 52 semanas 7.00
Capitalización de Mercado [m]
Precio Anterior
1.99
Precio de Apertura
2.77
Última hora de negociación
Volumen financiero
US$ 96,959,028
Precio Promedio Ponderado
2.5129
Volumen promedio (3 m)
543,798
Acciones en circulación
21,238,378
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-
turnover
-
Beneficio neto
-6.38M

Acerca de OS Therapies Incorporated

OS Therapies (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OS Therapies was launched to meet significant unmet need for new treatments in cancers of the bone in kids and adult... OS Therapies (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OS Therapies was launched to meet significant unmet need for new treatments in cancers of the bone in kids and adults. Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. At OST, we are trying to answer the calls for new treatments, considering there have been no new treatments for OS in over 30 years. OST has expanded the pipeline beyond Osteosarcoma with OST-HER2 into other solid tumors with the same recurrence mechanism of action, including Breast, Esophageal and Lung cancer. With the addition of OST-tADC, considered a next generation Antibody Drug Conjugate (ADC) platform technology, we will be targeting Ovarian, Lung and Pancreatic cancer. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Middletown, Delaware, USA
Fundado
-
OS Therapies Incorporated is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker OSTX. The last closing price for OS Therapies was US$1.99. Over the last year, OS Therapies shares have traded in a share price range of US$ 1.58 to US$ 7.00.

OS Therapies currently has 21,238,378 shares in issue. The market capitalisation of OS Therapies is US$42.26 million.

OSTX Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.062.97029702972.022.18991.781272001.92425684CS
4-2.01-49.14425427874.094.091.713729092.43011155CS
120.2211.82795698921.8671.715437983.87646942CS
26-1.41-40.40114613183.4971.582652903.81940942CS
52-1.92-48471.582986323.82527872CS
156-1.92-48471.582986323.82527872CS
260-1.92-48471.582986323.82527872CS

OSTX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de OS Therapies?
El precio actual de las acciones de OS Therapies es US$ 2.08
¿Cuántas acciones de OS Therapies están en circulación?
OS Therapies tiene 21,238,378 acciones en circulación
¿Cuál es la capitalización de mercado de OS Therapies?
La capitalización de mercado de OS Therapies es USD 42.26M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de OS Therapies?
OS Therapies ha negociado en un rango de US$ 1.58 a US$ 7.00 durante el último año
¿Cuál es la moneda de reporte de OS Therapies?
OS Therapies presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de OS Therapies?
El último beneficio anual de OS Therapies es USD -6.38M
¿Cuál es la dirección registrada de OS Therapies?
La dirección registrada de OS Therapies es 18 MANASSAS DRIVE, MIDDLETOWN, DELAWARE, 197093802
¿Cuál es la dirección del sitio web de OS Therapies?
La dirección del sitio web de OS Therapies es www.ostherapies.com
¿En qué sector industrial opera OS Therapies?
OS Therapies opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
LFBBStone Ridge 2063 Longevity Income ETF
US$ 179.799
(900.00%)
4
LIBDStone Ridge 2065 Inflation Protected Longevity Income ETF
US$ 264.619
(900.00%)
2
LFDRStone Ridge Durable Income ETF
US$ 187.184
(900.00%)
3
LIAXStone Ridge 2063 Inflation-Protected Longevity Income ETF
US$ 264.897
(900.00%)
7
LFBEStone Ridge 2065 Longevity Income ETF
US$ 186.164
(900.00%)
3
HODLVanEck Bitcoin ETF
US$ 27.53
(-74.73%)
1.07M
ATCHAtlasClear Holdings Inc
US$ 2.65
(-19.70%)
490.18k
SCPXScorpius Holdings Inc
US$ 0.2798
(-17.71%)
1.75M
DXFEason Technology Limited
US$ 16.10
(-14.09%)
27.28k
YCBDcbdMD Inc
US$ 0.495
(-13.16%)
1.58M
FXIiShares China Large Cap
US$ 35.065
(2.65%)
61.58M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.86
(0.18%)
55.31M
DNNDenison Mines Corp
US$ 1.63
(-6.86%)
53.11M
KWEBKraneShares CSI China Internet
US$ 35.65
(3.81%)
48.43M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 28.55
(0.28%)
43.36M

OSTX Discussion

Ver más
Monksdream Monksdream 2 horas hace
OSTX under $3
👍️0
JPetroInc JPetroInc 23 horas hace
don't touch it...

unless you're Jack be nimble Jack be quick...

AJMHO
👍️0
tedpeele tedpeele 1 día hace
I'm seeing 1.6m float
👍️0
glenn1919 glenn1919 1 día hace
OSTX...................................................newone.....................................https://stockcharts.com/h-sc/ui?s=ostxp=W&yr=1&mn=3&dy=0&id=p96837884856
👍️0
tw0122 tw0122 1 día hace
$4.10 + 104% went to $5s last run January but profit taking hitting bigger now 
👍️0
JPetroInc JPetroInc 1 día hace
I wouldn't touch ANYTHING Gerald Commissiong is involved with...

did you see the last P&D they pulled in Dec., 24

AJMHO
👍️0
tw0122 tw0122 1 día hace
$3.36 + 70% Guess will find out later flip out time ..
 The Company anticipates submitting a Biologics Licensing Application (BLA) to the US FDA for OST-HER2 in osteosarcoma in 2025 and, if approved, would become eligible to receive a Priority Review Voucher that it could then sell. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing preclinical efficacy data in various models of breast cancer. OST-HER2 has been conditionally approved by the U.S. Department of Agriculture for the treatment of canines with osteosarcoma.

👍️0
JPetroInc JPetroInc 1 día hace
interesting - wonder where they'll get their funding

and if it will be toxic - Gerald...?
👍️0
tw0122 tw0122 1 día hace
OSTK 3.06 + 52% 
👍️0
tw0122 tw0122 1 día hace
OSTX $2.30 + 15% .. NEW YORK--(BUSINESS WIRE)--Feb. 14, 2025--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into agreements for the commercial manufacture of OST-HER2. 
👍️0
tw0122 tw0122 1 mes hace
Didn't trade it but see you under $4 maybe lol thanks
👍️0
TheFinalCD TheFinalCD 1 mes hace
https://x.com/brentkhack_TX/status/1879510244243783831
👍️0
tw0122 tw0122 1 mes hace
Lung action $8s + 92% 17m floater 
👍️0
JPetroInc JPetroInc 5 meses hace
looking good Gerald...!

IMHO, you'll have this trading at $0.00028 in record time



here comes the Astoria Queens financial mafia wrecking crew to help assist you in your next financial debacle

so much for running TOMDF into insolvency and jumping ship to this firm which didn't last long:

Fortitude Advisors LLC

https://fortitudeadvisors.com/team/

"He is also the Chief Business Officer at OS Therapies, Inc. starting in 2024 and the Managing Partner at Fortitude Advisors LLC since 2019."

https://uk.marketscreener.com/insider/GERALD-COMMISSIONG-A19LFK/

I give Gerald Commissiong 6 months before OSTX fire's his arse - and for good measure...!

MOO pathetic
👍️0
JPetroInc JPetroInc 5 meses hace
uh ho - Gerald Commissiong OSTX's new Chief Business Officer executive named...

and is the same old same old serial dilution 'scam artist' from AMBS & TOMDF

here we go again folks...!



buyers be ware - check these other 2 tickers for the catastrophic results by this Stanford Univ. Financial Engineering hack

https://ostherapies.com/leadership/

SMH - can't make this stuff up - sad but true...!

MOO tool
👍️0

Su Consulta Reciente

Delayed Upgrade Clock